The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
California’s legalization of cannabis for adult-use may have reduced the stigma of using cannabis products during pregnancy and made them easier to obtain, according to new research from Kaiser Permanente investigators.
Kelly Young-Wolff, PhD, MPH, a clinical psychologist and Kaiser Permanente Division of Research investigator who studies substance use among vulnerable populations, including pregnant women, was awarded the 2022 Young Professional Award by the American Public Health Association (APHA) Maternal and Child Health (MCH) Section.
The number of women using cannabis in the year before they get pregnant and early in their pregnancies is increasing, and their frequency of use is also rising, according to new data from Kaiser Permanente.
A new study from the Division of Research, using data from almost 300,000 pregnant women treated at Kaiser Permanente Northern California, found that maternal prenatal marijuana use increased from 4 to 7 percent from 2009 to 2016.